Notice of Summer Holidays

We regret to inform you that we will be closed during the following period.
August 10 – 15, 2024
Inquiries received during this period will be handled in order from August 16.

Notice of Summer Holidays

We would like to inform you of our summer holiday schedule.

Summer holiday period: August 11, 2023 (Fri.) – August 15, 2023 (Tue.)

We will reply to your inquiries during the summer holiday in order from Wednesday, August 16.

We apologize for any inconvenience this may cause and appreciate your understanding.


The office will be closed for Golden Week from May 3, 2023 to May 7, 2023.
Responses to inquiries and correspondence will be handled from May 8, 2023.

MOBILE ROSE was published in Endocrine Journal by the Japanese Endocrine Society (head author: Dr. Toshitetsu Hayashi, Mitsuyoshi Hirokawa, et al., Kuma Hospital, coauthor; Noriko Akiyama).

A joint paper with Kuma Hospital, one of the leading thyroid hospitals in Japan, was published in Endocrine Journal, a publication of the Japanese Endocrine Society.

According to this paper, 57.1% of the cases that were found to be inappropriate or unknown in the rapid adequacy assessment of thyroid gland by naked eyes were confirmed to have cells by using Mobile Rose and were considered appropriate.

The clinical utility of Mobile Rose has been shown to prevent unnecessary re-sampling.

For more information, please click on the link below.

[PDF]Kuma Hospital MRPaper(3.5MB)

Mobile Rose project has been selected for the Ministry of Economy, Trade and Industry’s Business Restructuring Grant Program!

March 26, 2021, “The Ministry of Economy, Trade and Industry (METI) has announced that it will “support the challenges of small and medium-sized enterprises (SMEs) that are willing to undertake drastic business restructuring, such as expansion into new fields, change of business category, change of business or industry, business restructuring, or expansion of scale through these initiatives.Our project using MOBILE ROSE (development and market deployment of MOBILE ROSE, the world’s first microscope that supports rapid on site evaluation) was adopted.

[Proposal from the Japanese Society for Clinical Cytology] Regarding the indications for cytological examination (mainly ROSE) in COVID-19 patients

The Japanese Society of Clinical Cytology (JSCC) has issued the following recommendations regarding ROSE in coronavirus pandemic.

  1. In principle, the presence of COVID-19 infection itself does not preclude the use of ROSE, but it may be used only when the advantages from a medical standpoint outweigh the disadvantages, and when adequate protection can be provided.

  2. In principle, the tests should be conducted when there is adequate reserve for protective clothing, and when it is necessary to conduct the tests immediately.

  3. In municipalities where a state of emergency has been declared, consideration should be given to suspending the implementation of non-urgent cases in order to limit the flow of people.

(Reference: The official website of the Japanese Society of Clinical Cytology)